Voya Investment Management LLC Neoleukin Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $12,616 - $30,856	-13,714 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $2,785 - $4,642	-599 Reduced 4.19%	13,714 $66,000
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $498 - $708	-54 Reduced 0.38%	14,313 $132,000
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $4,188 - $5,870	-372 Reduced 2.52%	14,367 $177,000
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $39,947 - $57,191	-3,928 Reduced 21.04%	14,739 $208,000
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $80,953 - $142,254	8,363 Added 81.16%	18,667 $224,000
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $102,524 - $175,683	10,304 New	10,304 $171,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.